TrianglePUBLICATIONS · 38603646
Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2024 Jun 20
- First author
- Tierens A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Tierens A
- type
- Author
- name
- Arad-Cohen N
- type
- Author
- name
- Cheuk D
- type
- Author
- name
- De Moerloose B
- type
- Author
- name
- Fernandez Navarro JM
- type
- Author
- name
- Hasle H
- type
- Author
- name
- Jahnukainen K
- type
- Author
- name
- Juul-Dam KL
- type
- Author
- name
- Kaspers G
- type
- Author
- name
- Kovalova Z
- type
- Author
- name
- Lausen B
- type
- Author
- name
- Norén-Nyström U
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Tierens A
- type
- Author
- name
- Arad-Cohen N
- type
- Author
- name
- Cheuk D
- type
- Author
- name
- De Moerloose B
- type
- Author
- name
- Fernandez Navarro JM
- type
- Author
- name
- Hasle H
- type
- Author
- name
- Jahnukainen K
- type
- Author
- name
- Juul-Dam KL
- type
- Author
- name
- Kaspers G
- type
- Author
- name
- Kovalova Z
- type
- Author
- name
- Lausen B
- type
- Author
- name
- Norén-Nyström U
- type
- Author
- bibliography ids
- nci-bib-084cca887a2504a379a2388b
- book metadata
- content sha256
- 9d23a7331f8cd00e032849e71678b54b35e02f9fe765947776ba99ea1148a9de
- document type
- citation
- dois
- 10.1200/JCO.23.01841
- electronic publication date
- display
- 2024 Apr 11
- precision
- day
- year
- 2024
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38603646
- immutable id
- pubmed:38603646@9d23a7331f8cd00e032849e71678b54b35e02f9fe765947776ba99ea1148a9de
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 18
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2174-2185
- volume
- 42
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38603646
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- a4ea644ad2bf008fcc356a10d6fa8762e6a30c2730c9d5755d8721aa9a5c0b63
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2024 Jun 20
- precision
- day
- year
- 2024
- publication types
- Journal Article
- Clinical Trial, Phase III
- Randomized Controlled Trial
- Comparative Study
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease.
Preserved source evidence · Not medical advice